Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.800
0.00 (0.00%)
At close: Feb 6, 2026
HRGN Revenue
Harvard Apparatus Regenerative Technology had revenue of $123.00K in the quarter ending September 30, 2025, with 108.47% growth. This brings the company's revenue in the last twelve months to $743.00K, up 216.17% year-over-year. In the year 2024, Harvard Apparatus Regenerative Technology had annual revenue of $430.00K with 317.48% growth.
Revenue (ttm)
743.00K
Revenue Growth
+216.17%
P/S Ratio
42.59
Revenue / Employee
92.88K
Employees
8
Market Cap
31.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 430.00K | 327.00K | 317.48% |
| Dec 31, 2023 | 103.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHarvard Apparatus Regenerative Technology News
- 20 days ago - Harvard Apparatus Regenerative Technology Collaborates with University of Southern California to Test Treatment for Esophageal Disease - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children's Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 years ago - Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 years ago - Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy - GlobeNewsWire
- 2 years ago - Harvard Apparatus Regenerative Technology and Renowned Professor/Physician Establish a Collaboration to Repair and Regenerate the Uterus - GlobeNewsWire